It was announced today that Sahajanand Medical Technologies (SMT) is establishing its European headquarters which will have a state-of-the-art Research, Development and Innovation Centre in Galway- Ireland, creating 50 jobs over five years.
SMT is largest developer and manufacturer of minimally invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. The company has received numerous awards for its breakthrough innovations and quality that have led to more thinner and flexible DES with good long term clinical results.
The project is supported by the Department of Jobs, Enterprise & Innovation through IDA Ireland.
Speaking at today’s announcement, SMT’s Western European Head, Mr. Gaurav Goel said: “We were pioneers among Indian medical device companies to identify tremendous value in investing in research & development (R&D). Our core strength lies in our ability to excel in developing technologically complex products through focused teams. With this centre, we hope to tap into the excellent talent pool available in Galway to make further enhancements in existing products and to develop new and innovative products.”
Pleased on the partnership, Tanaz Buhariwalla, Country Director India, IDA Ireland said, “IDA is very excited about SMT setting up base in Ireland, as it reinforces the country’s stronghold in the Medical Devices and Pharma sectors. Europe is a prime target for Indian companies especially in the technology, business services and life sciences sectors where a mature market offers opportunities for growth. Ireland is home to a number of India’s largest and best known global companies. Over 35 Indian companies have set up in Ireland to leverage Ireland as their gateway to Europe and markets beyond. IDA Ireland in India continues to have a robust pipeline for 2017 as Ireland offers a gateway to barrier-free access to Europe’s 500 million consumers.”
IDA Ireland’s CEO Martin Shanahan said: “I am delighted to welcome SMT to Galway. This is an important win for the West Region in line with our strategy to promote investment in regional locations. It will act as a valuable reference seller for us in attracting other companies in the Medical Technologies sector to the region. I wish Gaurav and his team here in Galway every success.”